Department of Internal Medicine, Cardiology Division, The University of Texas-McGovern Medical School, 1941 East Road, Houston, TX 77054, USA.
Cells. 2023 Feb 1;12(3):471. doi: 10.3390/cells12030471.
NO-stimulated guanylyl cyclase (SGC) is a hemoprotein that plays key roles in various physiological functions. SGC is a typical enzyme-linked receptor that combines the functions of a sensor for NO gas and cGMP generator. SGC possesses exclusive selectivity for NO and exhibits a very fast binding of NO, which allows it to function as a sensitive NO receptor. This review describes the effect of various cellular factors, such as additional NO, cell thiols, cell-derived small molecules and proteins on the function of SGC as cellular NO receptor. Due to its vital physiological function SGC is an important drug target. An increasing number of synthetic compounds that affect SGC activity via different mechanisms are discovered and brought to clinical trials and clinics. Cellular factors modifying the activity of SGC constitute an opportunity for improving the effectiveness of existing SGC-directed drugs and/or the creation of new therapeutic strategies.
非刺激型鸟苷酸环化酶(SGC)是一种在多种生理功能中发挥关键作用的血红素蛋白。SGC 是一种典型的酶联受体,它将 NO 气体传感器和 cGMP 生成酶的功能结合在一起。SGC 对 NO 具有独特的选择性,并且对 NO 的结合非常迅速,这使其能够作为一种敏感的 NO 受体发挥作用。本文综述了各种细胞因子(如额外的 NO、细胞巯基、细胞衍生的小分子和蛋白质)对 SGC 作为细胞内 NO 受体功能的影响。由于其重要的生理功能,SGC 是一个重要的药物靶点。越来越多的通过不同机制影响 SGC 活性的合成化合物被发现并进行临床试验和临床应用。细胞因子修饰 SGC 活性为提高现有 SGC 靶向药物的疗效和/或创造新的治疗策略提供了机会。